273 related articles for article (PubMed ID: 21357301)
1. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.
Sasaki T; Takane H; Ogawa K; Isagawa S; Hirota T; Higuchi S; Horii T; Otsubo K; Ieiri I
Antimicrob Agents Chemother; 2011 May; 55(5):1867-73. PubMed ID: 21357301
[TBL] [Abstract][Full Text] [Related]
2. Linezolid-associated thrombocytopenia.
Lam S
Consult Pharm; 2012 Jul; 27(7):504-8. PubMed ID: 22910131
[TBL] [Abstract][Full Text] [Related]
3. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.
Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y
Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075
[TBL] [Abstract][Full Text] [Related]
4. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880
[TBL] [Abstract][Full Text] [Related]
5. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.
Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Kobayashi T; Sadoh S; Morita K; Kamimura H; Karube Y
J Infect Chemother; 2011 Feb; 17(1):70-5. PubMed ID: 20582446
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients.
Hirano R; Sakamoto Y; Tachibana N; Ohnishi M
Int J Clin Pharm; 2014 Aug; 36(4):795-9. PubMed ID: 24913359
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of linezolid in liver transplant patients.
Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
[TBL] [Abstract][Full Text] [Related]
9. Linezolid-Induced anemia and thrombocytopenia.
Waldrep TW; Skiest DJ
Pharmacotherapy; 2002 Jan; 22(1):109-12. PubMed ID: 11794421
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.
Keel RA; Schaeftlein A; Kloft C; Pope JS; Knauft RF; Muhlebach M; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3393-8. PubMed ID: 21518837
[TBL] [Abstract][Full Text] [Related]
11. Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci.
Kutscha-Lissberg F; Hebler U; Muhr G; Köller M
Antimicrob Agents Chemother; 2003 Dec; 47(12):3964-6. PubMed ID: 14638510
[TBL] [Abstract][Full Text] [Related]
12. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
[TBL] [Abstract][Full Text] [Related]
13. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction.
Tsuji Y; Yukawa E; Hiraki Y; Matsumoto K; Mizoguchi A; Morita K; Kamimura H; Karube Y; To H
J Clin Pharmacol; 2013 Sep; 53(9):967-73. PubMed ID: 23918457
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
Bounthavong M; Hsu DI
Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
Santos RP; Prestidge CB; Brown ME; Urbancyzk B; Murphey DK; Salvatore CM; Jafri HS; McCracken GH; Ahmad N; Sanchez PJ; Siegel JD
Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
[TBL] [Abstract][Full Text] [Related]
17. Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.
Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
J Infect Chemother; 2015 Jan; 21(1):70-3. PubMed ID: 25305808
[TBL] [Abstract][Full Text] [Related]
18. Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery.
Ikuta S; Tanimura K; Yasui C; Aihara T; Yoshie H; Iida H; Beppu N; Kurimoto A; Yanagi H; Mitsunobu M; Yamanaka N
J Infect Chemother; 2011 Jun; 17(3):388-91. PubMed ID: 21161560
[TBL] [Abstract][Full Text] [Related]
19. [Case report: severe thrombocytopenia].
Sakka SG; Schürmann A; Knüttgen D; Wappler F
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):242-5. PubMed ID: 19367527
[TBL] [Abstract][Full Text] [Related]
20. Use of linezolid in children.
Kaplan SL
Pediatr Infect Dis J; 2002 Sep; 21(9):870-2. PubMed ID: 12352813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
